XML 65 R52.htm IDEA: XBRL DOCUMENT v3.25.1
ACQUISITIONS, DIVESTITURES AND STRATEGIC INVESTMENTS - Divestiture of Whole Blood Product Line and Strategic Investments (Details)
€ in Thousands
12 Months Ended
Jan. 13, 2025
USD ($)
Mar. 29, 2025
USD ($)
Mar. 29, 2025
EUR (€)
Mar. 30, 2024
USD ($)
Mar. 30, 2024
EUR (€)
Apr. 01, 2023
USD ($)
Apr. 01, 2023
EUR (€)
Schedule of Investments [Line Items]              
Proceeds from divestiture and sale of assets   $ 43,291,000   $ 1,500,000   $ 850,000  
Inventories, net   (365,141,000)   (317,202,000)      
Property, plant and equipment, net   284,052,000   311,362,000      
Goodwill   604,269,000   565,082,000   466,231,000  
Gain (Loss) on Investments   0   0   $ 0  
Strategic Investments   7,000,000   $ 7,600,000      
Revision of Prior Period, Reclassification, Adjustment              
Schedule of Investments [Line Items]              
Inventories, net   26,400,000          
Property, plant and equipment, net   (7,800,000)          
Goodwill   (6,400,000)          
Accrued Liabilities   $ (100,000)          
Disposal Group, Not Discontinued Operations | Whole Blood              
Schedule of Investments [Line Items]              
Proceeds from divestiture and sale of assets $ 43,300,000            
Business Combination, Contingent Consideration, Asset $ 22,500,000            
Vivasure Medical LTD              
Schedule of Investments [Line Items]              
Strategic Investments | €     € 9,500   € 5,000   € 30,000